"Urologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY TRACT in either the male or the female.
| Descriptor ID |
D014571
|
| MeSH Number(s) |
C04.588.945.947 C12.758.820 C13.351.937.820
|
| Concept/Terms |
Urologic Neoplasms- Urologic Neoplasms
- Urological Neoplasms
- Neoplasm, Urological
- Neoplasms, Urological
- Urological Neoplasm
- Urinary Tract Neoplasms
- Neoplasm, Urinary Tract
- Neoplasms, Urinary Tract
- Tract Neoplasm, Urinary
- Tract Neoplasms, Urinary
- Urinary Tract Neoplasm
- Neoplasms, Urologic
- Neoplasm, Urologic
- Urologic Neoplasm
Cancer of Urinary Tract- Cancer of Urinary Tract
- Urinary Tract Cancers
- Urological Cancer
- Cancer, Urological
- Cancers, Urological
- Urological Cancers
- Cancer of the Urinary Tract
- Urinary Tract Cancer
- Cancer, Urinary Tract
- Cancers, Urinary Tract
- Urologic Cancer
- Cancer, Urologic
- Cancers, Urologic
- Urologic Cancers
|
Below are MeSH descriptors whose meaning is more general than "Urologic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urologic Neoplasms".
This graph shows the total number of publications written about "Urologic Neoplasms" by people in this website by year, and whether "Urologic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 5 | 0 | 5 |
| 2003 | 6 | 0 | 6 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 4 | 0 | 4 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 4 | 0 | 4 |
| 2010 | 7 | 1 | 8 |
| 2011 | 9 | 0 | 9 |
| 2012 | 5 | 0 | 5 |
| 2013 | 1 | 0 | 1 |
| 2014 | 8 | 0 | 8 |
| 2015 | 3 | 3 | 6 |
| 2016 | 9 | 0 | 9 |
| 2017 | 12 | 1 | 13 |
| 2018 | 6 | 0 | 6 |
| 2019 | 12 | 0 | 12 |
| 2020 | 6 | 0 | 6 |
| 2021 | 7 | 1 | 8 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urologic Neoplasms" by people in Profiles.
-
Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. Am J Clin Pathol. 2024 Nov 04; 162(5):492-499.
-
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011. Cancer. 2025 Jan 01; 131(1):e35601.
-
Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis. Urol Oncol. 2024 Nov; 42(11):361-369.
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
-
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations. JNCI Cancer Spectr. 2024 Apr 30; 8(3).
-
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel. Clin Genitourin Cancer. 2024 Aug; 22(4):102091.
-
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma. Eur Urol Oncol. 2024 Aug; 7(4):933-943.
-
Circulating and urinary tumour DNA in urothelial carcinoma?- upper tract, lower tract and metastatic disease. Nat Rev Urol. 2023 07; 20(7):406-419.
-
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly. Clin Genitourin Cancer. 2023 04; 21(2):301-308.
-
A 25-year perspective on the evolution of radiation treatment of urologic cancers. Urol Oncol. 2021 09; 39(9):577-581.